Prognica Labs

Prognica Labs is a life sciences company that combines artificial intelligence with laboratory work. It covers drug discovery, multi-omics analysis, wet-lab validation and diagnostics under one team, and has a presence in the Middle East, the United States, Canada and India.

What Prognica Labs offers

• AI drug discovery — target identification, drug repurposing, virtual screening, molecular dynamics and lead optimisation.
• Bioinformatics and multi-omics — analysis of combined omics data, finding and confirming biomarkers, and interpreting genetic variants to a clinical standard.
• Translational biology — wet-lab target validation and PCR and qPCR assay development, run by the scientists who made the prediction.
• Molecular diagnostics — tests that guide treatment choice, blood-based cancer testing, and building diagnostic kits up to a product ready for registration.
• AI platforms — five in-house platforms, including asset discovery and an in-silico evaluation suite.

Who it works with

Researchers, biotech companies, healthcare organisations, universities and other life sciences partners.

Key facts

• Service range: more than twenty specialised scientific services
• Regions: Middle East, United States, Canada, India
• Earlier focus: analysing medical images with deep learning to help predict and diagnose cancer